Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin

(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011

Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance

Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×

Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892

2007 Guidelines for the Management of Arterial Hypertension

Mancia, G., Backer, G. D., Dominiczak, A. F., Cífková, R., Fagard, R. H., Germanò, G., Grassi, G. M., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,870

European guidelines on cardiovascular disease prevention in clinical practice: executive summary

Graham, I., Atar, D., Borch‐Johnsen, K., Boysen, G., Burell, G. K., Cífková, R., Dallongeville, J., Backer, G. D., Ebrahim, S. B. J., Gjelsvik, B., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,865

The Cardiovascular Health Study: design and rationale.

Fried, L. P., Borhani, N. O., Enright, P., Furberg, C. D., Gardin, J. M., Kronmal, R. A., Kuller, L. H., Manolio, T. A., Mittelmark, M. B., Newman, A., et al. (1991) · Annals of Epidemiology · doi:10.1016/1047-2797(91)90005-w · Cited by 3,652

Diagnosis and Classification of diabetes mellitus

Rossi, G. (2014) · Diapedia.org eBooks · doi:10.14496/dia..20 · Cited by 3,212

International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes

The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185

Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy.

Rozanski, A., Blumenthal, J. A., & Kaplan, J. (1999) · Circulation · doi:10.1161/01.cir.99.16.2192 · Cited by 2,846

A scoping review of cardiovascular risk factor screening rates in general or family practice attendees living with severe mental ill-health

Xue, Y., Lewis, M., Furler, J., Waterreus, A. J., Dettmann, E., & Palmer, V. J. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.09.007 · Cited by 4

Cause-specific mortality and comorbid neurodevelopmental disorder in 167,515 patients with bipolar disorder: An entire population longitudinal study

Cho, W.-M., Hsu, T., Cheng, C., Chang, W.-H., Tsai, S., Bai, Y., Su, T., Chen, T., Chen, M., & Liang, C. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.12.007 · Cited by 5

Smoking cessation for patients on clozapine

Hert, M. A. F. D. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01722.x · Cited by 4

Excess non‐psychiatric hospitalizations among employees with mental disorders: a 10‐year prospective study of the GAZEL cohort

Silva, M. A. D., Lemogne, C., Melchior, M., Zins, M., van der Waerden, J. E. B., Consoli, S. M., Goldberg, M., Elbaz, A., Singh‐Manoux, A., & Nabi, H. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12341 · Cited by 4

Effects of an electronic reminder system on guideline-concordant treatment of psychotic disorders

Franke, I., Thier, S., & Riecher‐Rössler, A. (2016) · Neuropsychiatrie · doi:10.1007/s40211-016-0202-1 · Cited by 4

An Investigation of Cardiovascular Risks in a Group of Children and Adolescents Who Use Atypical Antipsychotics

Dıkeç, G., Arabacı, L. B., Uzunoğlu, G., & Mızrak, S. D. (2017) · Issues in Mental Health Nursing · doi:10.1080/01612840.2017.1355946 · Cited by 4

Establishing post mortem criteria for the metabolic syndrome: an autopsy based cross-sectional study

Christensen, M. R., Bugge, A. B. D., Malik, M. E., Thomsen, J. L., Lynnerup, N., Rungby, J., & Banner, J. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0339-0 · Cited by 4

Le risque cardiovasculaire global des patients atteints de schizophrénie hospitalisés en psychiatrie au CHU de Saint-Étienne

Abidi, O., Vercherin, P., Massoubre, C., & Bois, C. (2018) · L Encéphale · doi:10.1016/j.encep.2018.06.008 · Cited by 4

The Health Improvement Profile for people with severe mental illness: Feasibility of a secondary analysis to make international comparisons

Bos, D., Gray, R. J., Meepring, S., White, J., Foland, K., & Bressington, D. T. (2021) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/jpm.12748 · Cited by 6

Somatische Morbidität psychisch Kranker

Hewer, W., & Schneider, F. W. (2016) · Springer eBooks · doi:10.1007/978-3-662-50345-4_44 · Cited by 4

Diagnosis and management of hyperglycaemia in patients treated with antipsychotic drugs

Kosmalski, M., Różycka-Kosmalska, M., Basiak, M., Okopień, B., & Pietras, T. (2022) · Endokrynologia Polska · doi:10.5603/ep.a2022.0071 · Cited by 4

Salsalate and/or metformin therapy confer beneficial metabolic effects in olanzapine treated female mice

Shamshoum, H., Medak, K. D., McKie, G. L., Jeromson, S., Hahn, M., & Wright, D. C. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115671 · Cited by 4

Detection and early intervention for psychosis

Pradhan, A., & Joshi, H. (2018) · InnovAiT Education and inspiration for general practice · doi:10.1177/1755738018809453 · Cited by 4

Clinical profile and correlates of hospital stay in patients with severe mental illness

Kar, S. K., Roy, P., Singh, J. V., Tripathi, A., & Dalal, P. (2019) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2019.08.014 · Cited by 6

Cardio-metabolic abnormalities among patients with severe mental illness at a Regional Referral Hospital in southwestern Uganda

Agaba, D. C., Migisha, R., Katamba, G., & Ashaba, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235956 · Cited by 4

Diabetes self-management in people with severe mental illness

McBain, H. B., Mulligan, K., Haddad, M., Flood, C., Jones, J., Chapman, J., Hilton, N., & Simpson, A. (2014) · City Research Online (City University London) · Cited by 4

Use of ziprasidone in patients with schizophrenia in four European countries

Montes, J. M. G. (2011) · European Psychiatry · doi:10.1016/s0924-9338(11)71711-4 · Cited by 4

Knowledge about HIV in People with Schizophrenia: A General Population Comparison

Binder, M. D., Trappeniers, L., Wampers, M., Damme, P. V., Hal, G. F. V., & Peuskens, J. (2011) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.5.2.4 · Cited by 4

Amélioration de la santé cardiovasculaire par l’exercice physique chez les individus atteints de schizophrénie : un guide de pratique

Chalfoun, C., Abdel‐Baki, A., Letendre, E. D., Proulx, C., & Karelis, A. D. (2014) · Obésité · doi:10.1007/s11690-014-0450-9 · Cited by 4

Antipsychotics: features of undesirable adverse reactions in elderly and senile age

Ostroumova, O. D., Васильевна, Г. И., Isaev, R. I., & Pereverzev, A. P. (2019) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2019119021105 · Cited by 4

The Impact of Smoking Cessation on Hospitalization and Psychiatric Medication Utilization among People with Serious Mental Illness

Kertes, J., Stein-Reisner, O., Grunhaus, L. J., & Neumark, Y. D. (2021) · Substance Use & Misuse · doi:10.1080/10826084.2021.1942057 · Cited by 4

Psychopharmakotherapie bei Herz-Kreislauf-Erkrankungen

Cordes, J., Lange‐Asschenfeldt, C., Hiemke, C., & Kahl, K. G. (2012) · Der Internist · doi:10.1007/s00108-012-3070-1 · Cited by 4

Health Care Expenditures Among Individuals With Chronic Psychotic Disorders in Ontario: An Analysis Over Time

de Oliveira, C., Iwajomo, T., & Kurdyak, P. A. (2022) · Frontiers in Health Services · doi:10.3389/frhs.2022.848072 · Cited by 4

Psychiatric Disorders and Diabetes

Holt, R. I. G., & Citrome, L. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch57 · Cited by 4

The organisation and delivery of diabetes services in the UK: a scoping exercise.

Forbes, A., Hughes, J., Ismail, K., & While, A. (2010) · Research Portal (King's College London) · Cited by 4

Outcomes of a pilot feasibility study of comprehensive geriatric assessment for younger frail patients with severe mental illness

Arnautovska, U., Soole, R., Kwan, W. W. L., Reid, N., Baker, A., Gordon, E. H., Hubbard, R. E., Siskind, D. J., & Warren, N. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06830-3 · Cited by 3

Drawbacks of Olanzapine Therapy: An Emphasis on Its Metabolic Effects and Discontinuation

Oruch, R., Rajab, H. A., Elderbi, M., Pryme, I. F., Fasmer, O. B., & Lund, A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14228125 · Cited by 3

Dietetic Prescriptions in Bipolar Disorder: Nutritional Strategies to Support Mood Stability and Reduce Relapse Risk—A Narrative Review

Marano, G., Marzo, E. M., Sfratta, G., Traversi, G., Capristo, E., Gaetani, E., & Mazza, M. (2026) · Life · doi:10.3390/life16010146 · Cited by 3

Correlation between vaspin and PANSS scores in schizophrenia patients with obesity

Ertekin, H., Uysal, S., Aydın, M., İlhan, B. Ç., & Ertekin, Y. H. (2020) · The International Journal of Psychiatry in Medicine · doi:10.1177/0091217420905463 · Cited by 3

Amylin receptor agonism enhances the effects of liraglutide in protecting against the acute metabolic side effects of olanzapine

Medak, K. D., Jeromson, S., Bellucci, A., Arbeau, M., & Wright, D. C. (2023) · iScience · doi:10.1016/j.isci.2023.108628 · Cited by 3

A feasibility study of high intensity interval training intervention in inpatient mental health settings

Martland, R., Onwumere, J., Stubbs, B., & Gaughran, F. (2024) · Psychiatry Research Communications · doi:10.1016/j.psycom.2024.100173 · Cited by 3

Mental health care use and quality among Medicaid adults with serious mental illness receiving care at Federally Qualified Health Centers vs. other settings

Myong, C., Yang, Z., Behr, C., & Fung, V. (2024) · BMC Health Services Research · doi:10.1186/s12913-024-11308-1 · Cited by 3

Risk of retinal disease and visual impairment in individuals with psychiatric disorders

Chu, J., Shaia, J. K., Jeong, H., Singh, R. P., & Talcott, K. E. (2025) · Eye · doi:10.1038/s41433-025-03851-w · Cited by 3

Cost-Efficiency of Laboratory Testing among Psychiatric Inpatients

López‐Castromán, J., Blasco-Fontecilla, H., Paz-Yepes, M., Ferrer, A., de León-Martínez, V., Alvarez, R., & Baca‐García, E. (2012) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.44.3.c · Cited by 3

The value of counting WHO-defined cardiovascular risk factors for death and disability in a national sample of adults with psychosis

Hahn, L. A., Mackinnon, A. J., Foley, D. L., Morgan, V. A., Waterreus, A. J., Watts, G. F., Castle, D. J., Liu, D., & Galletly, C. A. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.09.028 · Cited by 3

Fysieke activiteit en schizofrenie: wetenschappelijke evidentie en concrete richtlijnen

Vancampfort, D., Knapen, J., Probst, M., & Binder, M. D. (2011) · Lirias (KU Leuven) · Cited by 3

Kronik Ruhsal Hastalığı Olan Bireylerde Diyabet Yönetimi ve Psikiyatri Hemşiresinin Rolü

İnce, S. Ç., & Günüşen, N. P. (2020) · Etkili Hemşirelik Dergisi · doi:10.46483/deuhfed.650821 · Cited by 3

New D2R partial agonist candidates: an in silico approach from statistical models, molecular docking, and ADME/Tox properties

da Silva, A. P., Chiari, L. P. A., Guimarães, A. R., Honório, K. M., & da Silva, A. B. F. (2021) · Structural Chemistry · doi:10.1007/s11224-021-01742-w · Cited by 3

Study protocol for a pilot high-intensity interval training intervention in inpatient mental health settings: a two-part study using a randomised controlled trial and naturalistic study design

Martland, R., Onwumere, J., Stubbs, B., & Gaughran, F. (2021) · Pilot and Feasibility Studies · doi:10.1186/s40814-021-00937-6 · Cited by 3

Comorbidity

Fountoulakis, K. N. (2014) · Springer eBooks · doi:10.1007/978-3-642-37216-2_10 · Cited by 3

Impaired long-term outcomes of patients with schizophrenia spectrum disorder after coronary artery bypass surgery: nationwide case–control study

Kallio, M., Korkeila, J. A., Malmberg, M., Gunn, J. M., Rautava, P. T., Korhonen, P. E., & Kytö, V. (2022) · BJPsych Open · doi:10.1192/bjo.2022.10 · Cited by 3

Schizophrene Psychosen

Falkai, P., Schennach, R., Lincoln, T. M., Schaub, A., & Hasan, A. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_64 · Cited by 3

Antipsychotic drug prescription sequence analysis in relation to death occurrence and cardiometabolic drug usage: A retrospective longitudinal study

Zagożdżon, P., Dorozynski, P., Waszak, P. M., Harasimowicz, A., & Dziubich, T. (2022) · The European Journal of Psychiatry · doi:10.1016/j.ejpsy.2022.06.002 · Cited by 3

Addressing Health Inequities in People with Serious Mental Illness

Cabassa, L. J. (2023) · doi:10.1093/oso/9780190937300.001.0001 · Cited by 3

Special Population: Adults with Severe and Persistent Mental Health Disorders

Barnhouse, K., Clark, S., & Davis, J. W. (2023) · Springer eBooks · doi:10.1007/978-3-031-29171-5_25 · Cited by 4

Elevated risk of developing type 2 diabetes in people with a psychiatric disorder: What is the role of health behaviors and psychotropic medication?

Lindekilde, N., Díaz, L. J., Lasgaard, M., Henriksen, J. E., Scheuer, S. H., Andersen, G. S., Rubin, K. H., & Pouwer, F. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108591 · Cited by 3

Gewichtszunahme unter Therapie mit Psychopharmaka

Eder, J., Simon, M. S., Glocker, C., & Musil, R. (2023) · Der Nervenarzt · doi:10.1007/s00115-023-01534-z · Cited by 3

Dysfunction of the Gut Microbiome and its Onset Progression of Chronic and Mental Health Disorders

Ameen, A., Amir, A., Aziz, M. N., Irshad, A., Maryam, M., & Hayat, S. (2023) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2023175425 · Cited by 4

The implementation of exercise therapy within hospital-based mental healthcare: Delphi study

McMahen, C., Wright, K. E., Jackson, B., Stanton, R., Lederman, O., McKeon, G., Rosenbaum, S., & Furzer, B. J. (2024) · BJPsych Open · doi:10.1192/bjo.2024.717 · Cited by 3

Effets métaboliques indésirables des antipsychotiques

Fève, B. (2013) · Obésité · doi:10.1007/s11690-013-0365-x · Cited by 3

Trastornos afectivos y salud física, implicaciones de la comorbilidad con enfermedades médicas: una revisión de la literatura

Colomer, L., Anmella, G., Grande, I., & Vieta, E. (2020) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2020.02.002 · Cited by 3

Metabolic Syndrome in Patients with Severe Mental Illness Undergoing Psychiatric Rehabilitation Receiving High Dose Antipsychotic Medication

Ravindranath, B. V. (2012) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.106021 · Cited by 3

Promoting mental health in men

Haddad, M. (2013) · Nursing Standard · doi:10.7748/ns2013.03.27.30.48.e7203 · Cited by 5

Can metabolic side effects of antipsychotics be reversed by lifestyle changes?

Bolger, A., Verdolini, N., & Agius, M. A. (2014) · PubMed · Cited by 3

Care Plans in Community Mental Health: an Audit Focusing on People with Recent Hospital Admissions

Stanislaus, V., Bastiampillai, T. J., Harris, M., & Battersby, M. (2016) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-016-9504-0 · Cited by 4

Association of genetic risk scores with body mass index in Swiss psychiatric cohorts

Saigí-Morgui, N., Vandenberghe, F., Delacrétaz, A., Quteineh, L., Gholam‐Rezaee, M., Aubry, J., von Gunten, A., Kutalik, Z., Conus, P., & Eap, C. B. (2016) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000210 · Cited by 3

Providing leadership on a hidden issue: Where are the mental health nurses?

Wynaden, D., & Heslop, K. (2016) · International Journal of Mental Health Nursing · doi:10.1111/inm.12207 · Cited by 3

Factores de riesgo cardiovascular en usuarios con trastorno mental severo

Paños-Martínez, M., Moncunill, E. P., Santiago-Barragán, Á.-M., Marti-Mestre, M., Ortega, J. T., Escayola-Maranges, A. M., & Lázaro, A. G. (2016) · Enfermería Clínica · doi:10.1016/j.enfcli.2016.06.005 · Cited by 3

Antipsychotiques : quand et comment les prescrire ?

Tebeka, S., Airagnes, G., & Limosin, F. (2017) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2016.12.007 · Cited by 4

Health Education and Activity – Lessening The Inequalities in mental health (HEA – LTI mental health)

Richmond, G., Kenny, C., Ahmed, J., Stephenson, L., Lindsay, J., Earls, P., Mullin, D. S., & Ryland, H. (2017) · BMJ Quality Improvement Reports · doi:10.1136/bmjquality.u205156.w3484 · Cited by 3

Positionspapier: Psychische Erkrankungen und Diabetes mellitus

Abrahamian, H., Kautzky‐Willer, A., Rießland-Seifert, A., Fasching, P., Ebenbichler, C. F., Hofmann, P., & Toplak, H. (2012) · Wiener klinische Wochenschrift · doi:10.1007/s00508-012-0279-x · Cited by 3

The relation of atypical antipsychotic use and stress with weight in individuals at clinical high risk for psychosis

Hampton-Anderson, J. N., Trotman, H. D., Addington, J., Bearden, C. E., Cadenhead, K. S., Cannon, T. D., Cornblatt, B. A., Mathalon, D. H., McGlashan, T. H., Tsuang, M. T., et al. (2018) · Stress and Health · doi:10.1002/smi.2819 · Cited by 4

Abnormal serum potassium levels and 6-month all-cause mortality in patients co-treated with antipsychotic and diuretic drugs – A Danish register-based cohort study

Marcussen, M., Polcwiartek, C., Mills, E. H. A., Jirback, F., Bylin, P., Torp-Pedersen, C. T., Søgaard, P., & Kragholm, K. H. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.06.008 · Cited by 4

Effects of therapeutic lifestyle change mentoring on cardio-metabolic factors for schizophrenia

Lee, K., Choi, H., & Han, M. (2019) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2019.12.006 · Cited by 3

Appraisal of physical health guidelines for severe mental illness

Friend, N., Hughes, J. P., Kisely, S. R., Kumar, R., & Siskind, D. J. (2020) · Australian Health Review · doi:10.1071/ah20080 · Cited by 4

Willingness to be vaccinated against COVID-19 is equal in individuals with affective disorders and healthy controls

Fellendorf, F. T., Bonkat, N., Platzer, M., Schönthaler, E. M. D., Ratzenhofer, M., Bengesser, S., Dalkner, N., & Reininghaus, E. Z. (2022) · Vaccine X · doi:10.1016/j.jvacx.2022.100186 · Cited by 3

Improving the physical health of people with severe mental illness: The need for tailor made care and uniform evaluation of interventions

van Hasselt, F. M. (2013) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 3

Childhood Schizophrenia

Caplan, R. (2016) · Wiley eBooks · doi:10.1002/9781119125556.devpsy321 · Cited by 3

Cardiovascular Risk Evaluation in a Latin American Population With Severe Mental Illness: An Observational Study

Rivas, J., Miranda, C., Restrepo, A., Hernández, M., Erazo, J. M., Martínez, M. J., Lasso, J., López, L., & Gómez-Mesa, J. E. (2025) · Actas Españolas de Psiquiatría · doi:10.62641/aep.v53i4.1904 · Cited by 2

Romanian GPs Involvement in Caring for the Mental Health Problems of the Elderly Population: A Cross-Sectional Study

Sfetcu, R., Toma, D., Tudose, C., & Vlădescu, C. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.641217 · Cited by 2

Prevalence of mental health disorders and their association with chronic physical diseases in Kuwait

Al-Ozairi, A., Irshad, M., Alsarraf, F., Raina, S., Alsaraf, H., & Al‐Ozairi, E. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1658457 · Cited by 3

The DIAMONDS intervention for type 2 diabetes for people with severe mental illness: findings from a single-group feasibility study

Brown, J. V. E., Carswell, C., Podmore, D., Featherstone, I., Alderson, S. L., Böhnke, J. R., Doran, T., Hadjiconstantinou, M., Hewitt, C. E., Holt, R. I. G., et al. (2025) · Frontiers in Health Services · doi:10.3389/frhs.2025.1688787 · Cited by 3

Psychokardiologie

Kahl, K. G., Stapel, B., Heitland, I., Lamadé, E. K., Pedraz-Petrozzi, B., & Deuschle, M. (2026) · Der Nervenarzt · doi:10.1007/s00115-025-01932-5 · Cited by 2

Diabetes series, 2. Diagnosis of diabetes mellitus

Nazarko, L. (2016) · British Journal of Healthcare Assistants · doi:10.12968/bjha.2016.10.9.422 · Cited by 2

Smoking and Smoking Cessation in the Patients with Major Psychiatric Disorders

Joe, K., Lee, K.-S., & Kim, D. (2010) · Journal of the Korean Society for Research on Nicotine and Tobacco · doi:10.25055/jksrnt.2010.1.2.96 · Cited by 2

Somatische Therapieverfahren

Hasan, A., & Falkai, P. (2016) · Elsevier eBooks · doi:10.1016/b978-3-437-22305-1.00006-5 · Cited by 2

The prevalence of type 2 diabetes in people with psychiatric disorders: an umbrella review protocol

Lindekilde, N., Scheuer, S. H., Rutters, F., Henriksen, J. E., Rubin, K. H., Lasgaard, M., Andersen, G. S., & Pouwer, F. (2020) · Systematic Reviews · doi:10.1186/s13643-020-01341-6 · Cited by 2

Adherence to smoking cessation guidelines (5As) by psychiatrists and primary care physicians for persons with serious mental illness

Kertes, J., Stein-Reisner, O., Grunhaus, L. J., & Neumark, Y. D. (2021) · Journal of Addictive Diseases · doi:10.1080/10550887.2021.2017203 · Cited by 2

Study protocol: a randomised, controlled trial of a nurse navigator program for the management of hepatitis C virus in patients with severe mental disorder

Quemada, C., Morales‐Asencio, J. M., Hurtado, M. M., & Martí‐García, C. (2022) · BMC Nursing · doi:10.1186/s12912-022-00870-w · Cited by 2

Shared Care Practices in Community Addiction and Mental Health Services: A Qualitative Study on the Experiences and Perspectives of Stakeholders

Foster, M., Weaver, J., Shalaby, R., Eboreime, E., Poong, K., Gusnowski, A., Snaterse, M., Surood, S., Urichuk, L., & Agyapong, V. I. O. (2022) · Healthcare · doi:10.3390/healthcare10050831 · Cited by 2

The Cumulative Effect of Antipsychotic Usage on Mortality in Schizophrenia: A Nationwide Population-based Cohort Study in Korea

Kim, G., Rim, S. J., Jo, M., Lee, M. G., Park, S. J., & Park, S. (2022) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2022.20.3.573 · Cited by 2

Propositions des professionnels pour réduire le risque cardiovasculaire des patients psychiatriques

Denis, F., Meunier‐Beillard, N., Costa, M., Guillermet, É., Rat, C., & Roelandt, J.-L. (2022) · Santé Publique · doi:10.3917/spub.225.0621 · Cited by 2

Psychological Care as an Interdisciplinary Approach in the Management of Diabetes: A Narrative Review of Literature

Górska-Ciebiada, M., & Ciebiada, M. (2022) · Clinical Diabetology · doi:10.5603/dk.a2022.0053 · Cited by 3

Validity and Reliability of a Mental Health Recovery Checklist for Young Adults

Cerrito, B. (2024) · International Journal of Mental Health Promotion · doi:10.32604/ijmhp.2024.047876 · Cited by 2

Nanoparticle Carriers for Drug Delivery: An Updated Review

Hajipour, S., & Ghiasvand, A. (2024) · Pharmaceutical Nanotechnology · doi:10.2174/0122117385340986241208123048 · Cited by 2

Exploring barriers to the COVID-19 vaccine in people with psychoses in Western Australia

Hall, T., Attwell, K., Morgan, V. A., Hincks, S., & Waterreus, A. J. (2025) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2025.103025 · Cited by 2

The BMIgap tool to quantify transdiagnostic brain signatures of current and future weight

Khuntia, A. T., Popovic, D., Sarisik, E., Buciuman, M.-O., Pedersen, M. L., Westlye, L. T., Andreassen, O. A., Meyer‐Lindenberg, A., Kambeitz, J. P., Salokangas, R. K. R., et al. (2025) · Nature Mental Health · doi:10.1038/s44220-025-00522-3 · Cited by 2

Somatische Morbidität psychisch Kranker

Hewer, W., Schneider, F. W., & Schneider, F. W. (2011) · Springer eBooks · doi:10.1007/978-3-642-17192-5_42 · Cited by 2

Cariprazine Use in Combination With a Mood Stabilizer in First Episode Mania

Palacios‐Garrán, R., Llorca-Bofí, V., Arteaga-Henríquez, G., & del Agua, E. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.828088 · Cited by 2

Monitoring and management of cardiometabolic risk factors in schizophrenia- A global perspective: rationale, aims and methods

Uwakwe, R., Ramachandran, P., Binder, M. D., Hasnain, M., Vancampfort, D., Omoaregba, J. O., Hjorth, P., Ifeoma, M., Imran, H. M., Placidus, O., et al. (2014) · University of Southern Denmark Research Portal (University of Southern Denmark) · Cited by 2

Risk Factors for Weight Gain and Metabolic Syndrome in Adolescents with Psychiatric Disorders: A Historical Prospective Study

Landau, Z., Hady-Cohen, R., Boaz, M., Krivoy, A., Amit, B. H., Zalsman, G., Levi, M., & Shoval, G. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0098 · Cited by 2

Prevalence and risk factors associated with fasting blood glucose levels in adults aged 30 years and older with disabilities: the results from an annual health check-up

Lin, J., Lin, L.-P., Lee, J., Liou, S.-W., Chen, Y.-J., Hsu, S., Liu, C.-T., Leu, Y.-R., & Wu, C.-L. (2013) · International Journal of Developmental Disabilities · doi:10.1179/2047387713y.0000000023 · Cited by 2

Diabetes in psychiatric disease

Holt, R. I. G. (2014) · Medicine · doi:10.1016/j.mpmed.2014.10.005 · Cited by 2

Diabetes and severe mental illness

Jennings, E. (2011) · British Journal of Wellbeing · doi:10.12968/bjow.2011.2.3.21 · Cited by 2

What effect will pharmacogenomics have on mental health nursing?

Currid, T., & Mutsatsa, S. H. (2013) · Neuropsychiatry · doi:10.2217/npy.13.33 · Cited by 2

Protocol for a systematic review of telephone delivered psychosocial interventions on relapse prevention, adherence to psychiatric medication and health risk behaviours in adults with a psychotic disorder

Beck, A. K., Baker, A., Turner, A., Haddock, G., Kelly, P. J., Berry, K., & Bucci, S. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-009985 · Cited by 2

The methodological and conceptual aspects of mortality studies in psychiatry

Biggeri, A., & Catelan, D. (2010) · Epidemiologia e Psichiatria Sociale · doi:10.1017/s1121189x00001548 · Cited by 2

Severe Mental Illnesses and Metabolic Syndrome: The Need for More Awareness and Better Care

Bala, C. G., Niţă, C., & Hâncu, N. (2016) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.1515/rjdnmd-2016-0001 · Cited by 2

Death connected to paralytic ileus due to the intake of antipsychotic drugs. Case report

Cicconi, M., Mangiulli, T., & Bolino, G. (2013) · Romanian Journal of Legal Medicine · doi:10.4323/rjlm.2013.181 · Cited by 2

Comportamento da pressão arterial sistêmica em pacientes submetidos a procedimentos cirúrgicos odontológicos

de Matos, J. D. M., Pereira, A. L. C., Lopes, G. D. R. S., Andrade, V. C., & Perez, E. G. (2018) · Revista da Faculdade de Odontologia - UPF · doi:10.5335/rfo.v23i3.8548 · Cited by 2

Cardiovasculaire ziekte en diabetes bij mensen met een ernstige psychiatrische stoornis

Binder, M. D., Dekker, J., Wood, D. V., Kahl, K., Holt, R., & Moller, H. (2010) · Lirias · doi:10.2143/tvg.66.06.2000714 · Cited by 1

Cardiovascular disease and diabetes in people with severe mental illness

Binder, M. D., Dekker, J. M., Wood, D. A., Kahl, K. G., & Möller, H. (2009) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/s2173-5050(09)70031-7 · Cited by 27

The EPA/EADS/ESC position statement on diabetes and cardiovascular risk in patients with severe mental disorders

Möller, H. (2010) · Annals of General Psychiatry · doi:10.1186/1744-859x-9-s1-s36

Maladie cardiovasculaire et diabète chez les personnes atteintes d'une maladie mentale sévère. 1ère partie: Epidémiologie et influence des médicaments psychotropes

Scheen, A. J., Gillain, B., & De Hert, M. (2010) · Lirias

Enfermedad cardiovascular y diabetes en personas con enfermedad mental grave

Hert, M. D., Dekker, J. M., Wood, D. A., Kahl, K. G., & Möller, H. (2009) · Revista de Psiquiatría y Salud Mental · doi:10.1016/s1888-9891(09)70714-1 · Cited by 23